Zentalis Pharmaceuticals (ZNTL) Total Liabilities (2019 - 2026)
Zentalis Pharmaceuticals (ZNTL) posted quarterly Total Liabilities of $70.4 million for Q1 2026, down 20.59% year-over-year from $88.6 million in Q1 2025, and down 3.27% quarter-over-quarter from $72.8 million in Q4 2025.
Zentalis Pharmaceuticals (ZNTL) Total Liabilities (2019 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' Total Liabilities history runs 8 years deep, the most recent figure standing at $70.4 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 20.59% year-over-year to $70.4 million; the TTM figure through Mar 2026 stood at $70.4 million (down 20.59% YoY), while the FY2025 annual figure was $72.8 million, down 21.89% from the prior year.
- Total Liabilities for Q1 2026 stood at $70.4 million, down from $72.8 million in the prior quarter.
- The five-year high for Total Liabilities was $114.3 million in Q4 2023, with the low at $70.4 million in Q1 2026.
- The 5-year median for Total Liabilities is $96.3 million (2024), against an average of $93.6 million.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities soared 161.42% in 2022, then retreated 29.23% in 2025.
- Zentalis Pharmaceuticals' Total Liabilities stood at $105.3 million in 2022, then advanced by 8.56% to $114.3 million in 2023, then decreased by 18.5% to $93.2 million in 2024, then dropped by 21.89% to $72.8 million in 2025, then retreated by 3.27% to $70.4 million in 2026.
- Business Quant data shows ZNTL's Total Liabilities at $70.4 million in Q1 2026, $72.8 million in Q4 2025, and $74.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Zentalis Pharmaceuticals | 255.14 Mn | 255.14 Mn | - | 71.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.68 Mn |
| Mar 31, 2026 | 70.39 Mn |
| Dec 31, 2025 | 72.76 Mn |
| Sep 30, 2025 | 74.38 Mn |
| Jun 30, 2025 | 77.21 Mn |
| Mar 31, 2025 | 88.64 Mn |
| Dec 31, 2024 | 93.15 Mn |
| Sep 30, 2024 | 96.33 Mn |
| Jun 30, 2024 | 109.10 Mn |
| Mar 31, 2024 | 98.71 Mn |
| Dec 31, 2023 | 114.30 Mn |
| Sep 30, 2023 | 103.82 Mn |
| Jun 30, 2023 | 98.16 Mn |
| Mar 31, 2023 | 103.68 Mn |
| Dec 31, 2022 | 105.29 Mn |
| Sep 30, 2022 | 100.46 Mn |
| Jun 30, 2022 | 95.03 Mn |
| Mar 31, 2022 | 90.01 Mn |
| Dec 31, 2021 | 90.03 Mn |
| Sep 30, 2021 | 41.09 Mn |